Novartis Seeks To Stop Hospira From Selling Zometa Generic
Novartis Pharmaceuticals Corp. launched a lawsuit against Hospira Inc. in New Jersey federal court Friday seeking to block the company's attempt to manufacture and sell generic versions of Novartis' cancer therapy...To view the full article, register now.
Already a subscriber? Click here to view full article